AGTR1 and glaucoma: –29 Furthermore, an angiotensin-converting enzyme inhibitor (captopril) and an angiotensin II type 1 receptor antagonist (candesartan) demonstrated neuroprotective effects against RGC damage in an animal glaucoma model.30